European Journal of Cardio-Thoracic Surgery · 2003 · 89 citations · 28 references
MedicineSurgeryEndocrine SurgeryGeneral SurgeryMinimally Invasive Neck SurgeryMyasthenia GravisSurgical Management Of HyperthyroidismBiochemical RemissionConversion To Sternotomy ManagementHospital Stay DurationOcular SymptomsPyridostigmine Treatment
OBJECTIVE: To study the impact of minimally invasive trans-cervical thymectomy on the incidence of remission of patients with myasthenia gravis (MG) in a single institution over a 10-year period. METHODS: A total of 120 consecutive patients referred for video-assisted trans-cervical thymectomy between 1991 and 2000 were included in the analysis. Complete remission was defined as no symptoms and no treatment for 6 months, and remission as minimal ocular symptoms (slight ptosis) or treatment with pyridostigmine only for 6 months. RESULTS: There were 86 females and 34 males with a median age of 33 (range 14-79) and 36 years (range 12-68), respectively. Symptoms of MG lasted between 2 months and 17 years before thymectomy (median 10 months). Surgery was converted to a partial upper sternotomy in 23 cases (19%). The median hospital stay decreased from 2 days (range 1-8) before 1994 to 1 day (range 1-8) thereafter (p<0.0001). Postoperative complications occurred in four patients (3.3%). After a median follow-up of 48 months (range 6-117 months), 50% of the patients were in complete remission (41%) or in remission (9%). Kaplan-Meier estimates rate of complete remission were 30% after 5 years of follow-up and 91% after 10 years. CONCLUSIONS: Minimally invasive trans-cervical thymectomy can be performed with short hospital stay and low morbidity, and achieve excellent durable results at 10 years.
28
"Maximal" thymectomy for myasthenia gravis. Results.
Alfred Jaretzki, Audrey S. Penn, David S. Younger et al. · PubMed · 1988 · 239 citations
THYMECTOMY IN THE TREATMENT OF MYASTHENIA GRAVIS
Alfred Blalock · Journal of Thoracic Surgery · 1944 · 182 citations